Showing results (51-60 of 73) with videos related to
Sort By:
Pageof 8
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 15, 2006
Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cellsGlenn A Van den Bosch, Ellen Van Gulck, Peter Ponsaerts, et al.Plos Pathogens|December 14, 2012
MiniCD4 microbicide prevents HIV infection of human mucosal explants and vaginal transmission of SHIV(162P3) in cynomolgus macaquesNathalie Dereuddre-Bosquet, Laurence Morellato-Castillo, Joachim Brouwers, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 16, 2014
Boosting of HIV-1 neutralizing antibody responses by a distally related retroviral envelope proteinHannes Uchtenhagen, Torben Schiffner, Emma Bowles, et al.Transboundary and Emerging Diseases|July 5, 2021
SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, BelgiumValeria Carolina Colombo, Vincent Sluydts, Joachim Mariën, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 11, 2023
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipientsDelphine Kemlin, Nicolas Gemander, Stéphanie Depickère, et al.The Journal of Infectious Diseases|June 2, 2016
Development, Evaluation, and Integration of a Quantitative Reverse-Transcription Polymerase Chain Reaction Diagnostic Test for Ebola Virus on a Molecular Diagnostics PlatformLieselotte Cnops, Peter Van den Eede, James Pettitt, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 22, 2022
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunitySean McCafferty, A K M Ashiqul Haque, Aster Vandierendonck, et al.Journal of Hematology & Oncology|October 25, 2021
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipientsLorenzo Canti, Stéphanie Humblet-Baron, Isabelle Desombere, et al.Nature Communications|August 24, 2023
SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populationsAndrew P Hederman, Harini Natarajan, Leo Heyndrickx, et al.Plos One|May 17, 2012
International network for comparison of HIV neutralization assays: the NeutNet report IILeo Heyndrickx, Alan Heath, Enas Sheik-Khalil, et al.Pageof 8